Hard-congestion limit of the p-system in the BV setting******

This note is concerned with the rigorous justification of the so-called hard congestion limit from a compressible system with singular pressure towards a mixed compressible-incompressible system modeling partially congested dynamics, for small data in the framework of BV solutions. We present a first convergence result for perturbations of a reference state represented by a single propagating large interface front, while the study of a more general framework where the reference state is constituted by multiple interface fronts is announced in the conclusion and will be the subject of a forthcoming paper. A key element of the proof is the use of a suitably weighted Glimm functional that allows to obtain precise estimates on the BV norm of the front-tracking approximation

Assessment of antioxidant and drug releasing properties of cellulose fabrics functionalized with polymeric nanoparticles as potential biofunctional garments

Drug administration through skin raised a great interest as a not invasive and sustained method to deliver active substances both at topical and systemic levels. Biofunctional textiles are a new class of materials that combine conventional fabrics with advanced drug delivery systems in order to develop a wearable functional biomaterial [1]. The present research aims to functionalize cellulosic fabrics (e.g. cotton and viscose) with curcumin (CUR)-loaded polycaprolactone (PCL) nanoparticles (NPs) in order to assess their potential as biofunctional garments. The NPs were produced by the flash nanoprecipitation technique in a confined impinging jet mixer. Such technology was proven to be a simple and scalable approach to produce polymeric nanoparticles; moreover it was successfully applied to curcumin encapsulation [2]. Nanoparticles were then characterized in terms of size and zeta potential by dynamic light scattering (DLS), while the loading capacity (LC%) and encapsulation efficiency (EE%) were measured by exploiting fluorescence spectroscopy. Cotton and viscose fabrics were functionalized by imbibition with the NPs suspensions and the effectiveness of the treatment was observed under wide-field fluorescence microscopy. The release properties of the nanoparticles suspensions were studied in vitro in a multicompartment rotating cell, while the curcumin release from textile support was tested ex vivo in a Franz diffusion cell using porcine skin as membrane. Furthermore, the antioxidant activity of the NPs and of the functionalized fabrics was measured by electron paramagnetic resonance spectroscopy. Curcumin loaded NPs were successfully prepared with good control of particle size and loading capacity, high stability over several days and encapsulation efficiency higher than 99%. Nanoparticles were successfully attached to the textiles material as evidenced by fluorescent imaging. The prepared materials showed an improved antioxidant activity and the capability of controlling curcumin release both in vivo and ex vivo. The present research shows the possibility of producing biofunctional materials by simple and scalable process and opens a route for a new generation of garments that can benefit people health

Commissioning and improvements of the instrumentation and launch of the scientific exploitation of OARPAF, the Regional Astronomical Observatory of the Antola Park

The OARPAF telescope is an 80-cm-diameter optical telescope installed in the Antola Mount Regional Reserve, in Northern Italy. We present the results of the characterization of the site, as well as developments and interventions that have been implemented, with the goal of exploiting the facility for scientific and educational purposes. During the characterization of the site, an average background brightness of 22.40mAB (B filter) to 21.14mAB (I) per arcsecond squared, and a 1.5″ to 3.0″ seeing, have been measured. An estimate of the magnitude zero points for photometry is also reported. The material under commissioning includes three CCD detectors for which we provide the linearity range, gain, and dark current; a 31-orders échelle spectrograph with R ∼ 8500 to 15,000 and a dispersion of n = 1.39 × 10 − 6 px − 1λ + 1.45 × 10 − 4 nm / px, where λ is expressed in nm. The scientific and outreach potential of the facility is proven in different science cases, such as exoplanetary transits and active galactic nuclei variability. The determination of time delays of gravitationally lensed quasars, the microlensing phenomenon, and the tracking and the study of asteroids are also discussed as prospective science cases

Multicentric Atrial Strain COmparison between Two Different Modalities: MASCOT HIT Study

Two methods are currently available for left atrial (LA) strain measurement by speckle tracking echocardiography, with two different reference timings for starting the analysis: QRS (QRS-LASr) and P wave (P-LASr). The aim of MASCOT HIT study was to define which of the two was more reproducible, more feasible, and less time consuming. In 26 expert centers, LA strain was analyzed by two different echocardiographers (young vs senior) in a blinded fashion. The study population included: healthy subjects, patients with arterial hypertension or aortic stenosis (LA pressure overload, group 2) and patients with mitral regurgitation or heart failure (LA volume–pressure overload, group 3). Difference between the inter-correlation coefficient (ICC) by the two echocardiographers using the two techniques, feasibility and analysis time of both methods were analyzed. A total of 938 subjects were included: 309 controls, 333 patients in group 2, and 296 patients in group 3. The ICC was comparable between QRS-LASr (0.93) and P-LASr (0.90). The young echocardiographers calculated QRS-LASr in 90% of cases, the expert ones in 95%. The feasibility of P-LASr was 85% by young echocardiographers and 88% by senior ones. QRS-LASr young median time was 110 s (interquartile range, IR, 78-149) vs senior 110 s (IR 78-155); for P-LASr, 120 s (IR 80-165) and 120 s (IR 90-161), respectively. LA strain was feasible in the majority of patients with similar reproducibility for both methods. QRS complex guaranteed a slightly higher feasibility and a lower time wasting compared to the use of P wave as the reference

The Role of Attitudes Toward Medication and Treatment Adherence in the Clinical Response to LAIs: Findings From the STAR Network Depot Study

Background: Long-acting injectable (LAI) antipsychotics are efficacious in managing psychotic symptoms in people affected by severe mental disorders, such as schizophrenia and bipolar disorder. The present study aimed to investigate whether attitude toward treatment and treatment adherence represent predictors of symptoms changes over time. Methods: The STAR Network \u201cDepot Study\u201d was a naturalistic, multicenter, observational, prospective study that enrolled people initiating a LAI without restrictions on diagnosis, clinical severity or setting. Participants from 32 Italian centers were assessed at three time points: baseline, 6-month, and 12-month follow-up. Psychopathological symptoms, attitude toward medication and treatment adherence were measured using the Brief Psychiatric Rating Scale (BPRS), the Drug Attitude Inventory (DAI-10) and the Kemp's 7-point scale, respectively. Linear mixed-effects models were used to evaluate whether attitude toward medication and treatment adherence independently predicted symptoms changes over time. Analyses were conducted on the overall sample and then stratified according to the baseline severity (BPRS < 41 or BPRS 65 41). Results: We included 461 participants of which 276 were males. The majority of participants had received a primary diagnosis of a schizophrenia spectrum disorder (71.80%) and initiated a treatment with a second-generation LAI (69.63%). BPRS, DAI-10, and Kemp's scale scores improved over time. Six linear regressions\u2014conducted considering the outcome and predictors at baseline, 6-month, and 12-month follow-up independently\u2014showed that both DAI-10 and Kemp's scale negatively associated with BPRS scores at the three considered time points. Linear mixed-effects models conducted on the overall sample did not show any significant association between attitude toward medication or treatment adherence and changes in psychiatric symptoms over time. However, after stratification according to baseline severity, we found that both DAI-10 and Kemp's scale negatively predicted changes in BPRS scores at 12-month follow-up regardless of baseline severity. The association at 6-month follow-up was confirmed only in the group with moderate or severe symptoms at baseline. Conclusion: Our findings corroborate the importance of improving the quality of relationship between clinicians and patients. Shared decision making and thorough discussions about benefits and side effects may improve the outcome in patients with severe mental disorders

Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both

Background and objective: Chronic obstructive pulmonary disease (COPD) and heart failure (HF) mutually increase the risk of being present in the same patient, especially if older. Whether or not this coexistence may be associated with a worse prognosis is debated. Therefore, employing data derived from the REPOSI register, we evaluated the clinical features and outcomes in a population of elderly patients admitted to internal medicine wards and having COPD, HF or COPD + HF. Methods: We measured socio-demographic and anthropometric characteristics, severity and prevalence of comorbidities, clinical and laboratory features during hospitalization, mood disorders, functional independence, drug prescriptions and discharge destination. The primary study outcome was the risk of death. Results: We considered 2,343 elderly hospitalized patients (median age 81 years), of whom 1,154 (49%) had COPD, 813 (35%) HF, and 376 (16%) COPD + HF. Patients with COPD + HF had different characteristics than those with COPD or HF, such as a higher prevalence of previous hospitalizations, comorbidities (especially chronic kidney disease), higher respiratory rate at admission and number of prescribed drugs. Patients with COPD + HF (hazard ratio HR 1.74, 95% confidence intervals CI 1.16-2.61) and patients with dementia (HR 1.75, 95% CI 1.06-2.90) had a higher risk of death at one year. The Kaplan-Meier curves showed a higher mortality risk in the group of patients with COPD + HF for all causes (p = 0.010), respiratory causes (p = 0.006), cardiovascular causes (p = 0.046) and respiratory plus cardiovascular causes (p = 0.009). Conclusion: In this real-life cohort of hospitalized elderly patients, the coexistence of COPD and HF significantly worsened prognosis at one year. This finding may help to better define the care needs of this population

The role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic

Specific immune suppression types have been associated with a greater risk of severe COVID-19 disease and death. We analyzed data from patients >17 years that were hospitalized for COVID-19 at the “Fondazione IRCCS Ca′ Granda Ospedale Maggiore Policlinico” in Milan (Lombardy, Northern Italy). The study included 1727 SARS-CoV-2-positive patients (1,131 males, median age of 65 years) hospitalized between February 2020 and November 2022. Of these, 321 (18.6%, CI: 16.8–20.4%) had at least one condition defining immune suppression. Immune suppressed subjects were more likely to have other co-morbidities (80.4% vs. 69.8%, p < 0.001) and be vaccinated (37% vs. 12.7%, p < 0.001). We evaluated the contribution of immune suppression to hospitalization during the various stages of the epidemic and investigated whether immune suppression contributed to severe outcomes and death, also considering the vaccination status of the patients. The proportion of immune suppressed patients among all hospitalizations (initially stable at <20%) started to increase around December 2021, and remained high (30–50%). This change coincided with an increase in the proportions of older patients and patients with co-morbidities and with a decrease in the proportion of patients with severe outcomes. Vaccinated patients showed a lower proportion of severe outcomes; among non-vaccinated patients, severe outcomes were more common in immune suppressed individuals. Immune suppression was a significant predictor of severe outcomes, after adjusting for age, sex, co-morbidities, period of hospitalization, and vaccination status (OR: 1.64; 95% CI: 1.23–2.19), while vaccination was a protective factor (OR: 0.31; 95% IC: 0.20–0.47). However, after November 2021, differences in disease outcomes between vaccinated and non-vaccinated groups (for both immune suppressed and immune competent subjects) disappeared. Since December 2021, the spread of the less virulent Omicron variant and an overall higher level of induced and/or natural immunity likely contributed to the observed shift in hospitalized patient characteristics. Nonetheless, vaccination against SARS-CoV-2, likely in combination with naturally acquired immunity, effectively reduced severe outcomes in both immune competent (73.9% vs. 48.2%, p < 0.001) and immune suppressed (66.4% vs. 35.2%, p < 0.001) patients, confirming previous observations about the value of the vaccine in preventing serious disease